Skip to main content

Epidemiology and Public Health

The broad purpose of the Epidemiology and Public Health research group is contributing to increase the available scientific evidence regarding preventive interventions, to promote health, and prevent morbidity and mortality from major diseases. Our group uses epidemiological methods to study etiology, surveillance, and efficacy of these interventions. We are primarily focused on epidemiology and prevention of infectious diseases, in both individual and population levels.
Main lines of research:

  • Vaccines: This research line includes the organization, participation and collaboration in different clinical trials related to the evaluation of the immunogenicity, efficacy and safety of different vaccines (e.g. Herpes Zoster, Respiratory Syncytial Virus, Influenza, Covid-19).
  • The epidemiology and prevention of healthcare acquired infections: This research line includes the evaluation of risk factors, characteristics, evolution, host, and impact of these infections. 
  • Clinical Epidemiology of Multiple Sclerosis: The objective of this project is to characterize the epidemiology of Multiple Sclerosis in Catalonia. 

Team

Susana Otero Romero

Susana Otero Romero

Head of group
Epidemiology and Public Health
Read more
Magda Campins Martí

Magda Campins Martí

Epidemiology and Public Health
Read more
Elisa Navarro Royo

Elisa Navarro Royo

Epidemiology and Public Health
Read more
Agustin Gayubas Jurado

Agustin Gayubas Jurado

Research assistant
Epidemiology and Public Health
Read more
Arnau Peñalver Piñol

Arnau Peñalver Piñol

Predoctoral researcher
Epidemiology and Public Health
Read more
Blanca  Borras  Bermejo

Blanca Borras Bermejo

Predoctoral researcher
Epidemiology and Public Health
Read more
Susana Otero Romero

Susana Otero Romero

Head of group
Epidemiology and Public Health
Read more
Magda Campins Martí

Magda Campins Martí

Epidemiology and Public Health
Read more
Elisa Navarro Royo

Elisa Navarro Royo

Epidemiology and Public Health
Read more
Agustin Gayubas Jurado

Agustin Gayubas Jurado

Research assistant
Epidemiology and Public Health
Read more
Arnau Peñalver Piñol

Arnau Peñalver Piñol

Predoctoral researcher
Epidemiology and Public Health
Read more
Blanca  Borras  Bermejo

Blanca Borras Bermejo

Predoctoral researcher
Epidemiology and Public Health
Read more

Research lines

Clinical epidemiology of Multiple Sclerosis

To characterize the epidemiology of multiple sclerosis (MS) in Catalonia, a prospective registry of new cases of MS in Catalonia was set up in 2009 with the participation of 21 hospitals throughout Catalonia. Prevalence and incidence studies based on this population-based registry are being performed. Recently, and in collaboration with the Center of Multiple Sclerosis of Catalonia (Cemcat), we have set up a prospective registry of vaccination in patients with Immuno-Mediated Inflammatory Disease (IMID) who are candidates for biological treatment with the aim of evaluating vaccine immunogenicity and safety that will allow establishing the best vaccination strategy. In addition, we will study the prevalence and impact of comorbidity on Multiple Sclerosis prognosis.

IP: Susana Otero Romero

Epidemiology of hospital-acquired infections

Includes the evaluation of risk factors, features, evolution, host, and impact of these infections. The group has been pioneer in the organization of a national prevalence surveillance project for nosocomial infections (EPINE) that is underway since 1990, allowing the analysis and monitoring of this data for investigational purposes. We are currently working in a multilevel analysis to evaluate the characteristics associated with nosocomial infections due to antibiotic resistant microorganisms, based on data of EPINE study (PI15/00787). We are also involved in the national study of device-related infections in intensive care units (ENVIN-Helics).

IP: Jose Angel Rodrigo Pendás

Vaccines

The group has participated in different phase II, III and IV clinical trials focused on the study of the immunogenicity, efficacy and safety of several preventive vaccines (e.g. influenza, human papilloma virus, hepatitis B, herpes zoster, respiratory syncytial virus…). Currently, our group has expanded its line of research on the adjuvanted recombinant Herpes Zoster vaccine testing its safety and immunogenicity in pediatric immunosuppressed patients and adults =50 years of age with a prior episode of Herpes Zoster. Regarding observational studies, the group is leading a population study about the incidence of herpes zoster by risk groups (PI15/02273). Our team has also started a new line of investigation for a Respiratory Syncytial Virus vaccine in healthy pregnant women.

IP: Xavier Martínez Gómez

Projects

Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en pacientres inmunodeprimidos.

IP: Magda Campins Martí
Collaborators: Manuel Hernández González, Rosa Lopez Martinez , Lluis Armadans Gil, Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: PI18/01887
Duration: 01/01/2019 - 30/06/2023

Estudio de comorbilidad y de inmunogenicidad vacunal en una cohorte prospectiva de pacientes con primeros brotes sugestivos de Esclerosis Múltiple

IP: Susana Otero Romero
Collaborators: Juliana Esperalba Esquerra, Mar Tintore Subirana, Laia Pinos Tella, Marta Rodríguez Barranco, Luciana Midaglia Fernandez, Sonia Maria Uriona Tuma, Anna Laura Salerno
Funding agency: Instituto de Salud Carlos III
Funding: 105270
Reference: PI19/01606
Duration: 01/01/2020 - 31/12/2022

DRIVE

IP: Susana Otero Romero
Collaborators: Ingrid Carbones Fargas, Eva del Amo Moran, Constanza Olivares Castillo
Funding agency: The Innovative Medicines Initiative
Funding: 164597.5
Reference: DRIVE_IMI2-2021
Duration: 01/10/2021 - 30/09/2022

Asymptomatic SARS-CoV-2 infection in nursing homes

IP: Blanca Borras Bermejo
Collaborators: -
Funding agency: Institut Català de la Salut
Funding: 0.01
Reference: ICS/ARTICLE_RESIDENT/2021/BORRAS
Duration: 28/06/2021 - 28/06/2021

Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en pacientres inmunodeprimidos.

IP: Magda Campins Martí
Collaborators: Manuel Hernández González, Rosa Lopez Martinez , Lluis Armadans Gil, Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: PI18/01887
Duration: 01/01/2019 - 30/06/2023

Estudio de comorbilidad y de inmunogenicidad vacunal en una cohorte prospectiva de pacientes con primeros brotes sugestivos de Esclerosis Múltiple

IP: Susana Otero Romero
Collaborators: Juliana Esperalba Esquerra, Mar Tintore Subirana, Laia Pinos Tella, Marta Rodríguez Barranco, Luciana Midaglia Fernandez, Sonia Maria Uriona Tuma, Anna Laura Salerno
Funding agency: Instituto de Salud Carlos III
Funding: 105270
Reference: PI19/01606
Duration: 01/01/2020 - 31/12/2022

Measuring brand-specific influenza vaccine effectiveness

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Magda Campins Martí, Cristina Andrés Vargés
Funding agency: The Innovative Medicines Initiative
Funding: 75438
Reference: DRIVE_IMI2-2020_SUBART11
Duration: 20/07/2020 - 30/09/2021

Características del paciente y del hospital asociadas a la infección nosocomial por microorganismos resistentes a antibiótios - un análisis multinivel

IP: Jose Angel Rodrigo Pendás
Collaborators: Susana Otero Romero
Funding agency: Instituto de Salud Carlos III
Funding: 21175
Reference: PI15/00787
Duration: 01/01/2016 - 30/11/2020

INCIDENCIA Y HOSPITALIZACIÓN POR HERPES ZÓSTER EN CATALUÑA ENTRE 2007 Y 2017

IP: Magda Campins Martí
Collaborators: Xavier Martínez Gómez, Sonia Maria Uriona Tuma
Funding agency: Instituto de Salud Carlos III
Funding: 24926
Reference: PI15/02273
Duration: 01/01/2016 - 30/11/2020

Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en pacientres inmunodeprimidos.

IP: Magda Campins Martí
Collaborators: Manuel Hernández González, Rosa Lopez Martinez , Lluis Armadans Gil, Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: PI18/01887
Duration: 01/01/2019 - 30/06/2023

Estudio de comorbilidad y de inmunogenicidad vacunal en una cohorte prospectiva de pacientes con primeros brotes sugestivos de Esclerosis Múltiple

IP: Susana Otero Romero
Collaborators: Juliana Esperalba Esquerra, Mar Tintore Subirana, Laia Pinos Tella, Marta Rodríguez Barranco, Luciana Midaglia Fernandez, Sonia Maria Uriona Tuma, Anna Laura Salerno
Funding agency: Instituto de Salud Carlos III
Funding: 105270
Reference: PI19/01606
Duration: 01/01/2020 - 31/12/2022

Características del paciente y del hospital asociadas a la infección nosocomial por microorganismos resistentes a antibiótios - un análisis multinivel

IP: Jose Angel Rodrigo Pendás
Collaborators: Susana Otero Romero
Funding agency: Instituto de Salud Carlos III
Funding: 21175
Reference: PI15/00787
Duration: 01/01/2016 - 30/11/2020

INCIDENCIA Y HOSPITALIZACIÓN POR HERPES ZÓSTER EN CATALUÑA ENTRE 2007 Y 2017

IP: Magda Campins Martí
Collaborators: Xavier Martínez Gómez, Sonia Maria Uriona Tuma
Funding agency: Instituto de Salud Carlos III
Funding: 24926
Reference: PI15/02273
Duration: 01/01/2016 - 30/11/2020

Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en pacientres inmunodeprimidos.

IP: Magda Campins Martí
Collaborators: Manuel Hernández González, Rosa Lopez Martinez , Lluis Armadans Gil, Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: PI18/01887
Duration: 01/01/2019 - 30/06/2023

Development of Robust and Innovative Vaccine Effectiveness (DRIVE)

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Magda Campins Martí, Cristina Andrés Vargés
Funding agency: The Innovative Medicines Initiative
Funding: 59690
Reference: DRIVE_IMI2-2018_SUBART11
Duration: 07/08/2018 - 30/09/2019

Características del paciente y del hospital asociadas a la infección nosocomial por microorganismos resistentes a antibiótios - un análisis multinivel

IP: Jose Angel Rodrigo Pendás
Collaborators: Susana Otero Romero
Funding agency: Instituto de Salud Carlos III
Funding: 21175
Reference: PI15/00787
Duration: 01/01/2016 - 30/11/2020

INCIDENCIA Y HOSPITALIZACIÓN POR HERPES ZÓSTER EN CATALUÑA ENTRE 2007 Y 2017

IP: Magda Campins Martí
Collaborators: Xavier Martínez Gómez, Sonia Maria Uriona Tuma
Funding agency: Instituto de Salud Carlos III
Funding: 24926
Reference: PI15/02273
Duration: 01/01/2016 - 30/11/2020

Development of Robust and Innovative Vaccine Effectiveness (DRIVE)

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Magda Campins Martí, Cristina Andrés Vargés
Funding agency: The Innovative Medicines Initiative
Funding: 59690
Reference: DRIVE_IMI2-2018_SUBART11
Duration: 07/08/2018 - 30/09/2019

Cobertura de vacunación antigripal y morbilidad asociada a gripe en gestantes

IP: Magda Campins Martí
Collaborators: Inés Zulema Calero Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 38115
Reference: PI12/02423
Duration: 01/01/2013 - 30/06/2017

Development of a universal inFLUenza vaccine based on Tandem CORE technology (FLUTCORE) Grant Agreement nº 602437

IP: Magda Campins Martí
Collaborators: Jose Angel Rodrigo Pendás, Susana Otero Romero, Xavier Martínez Gómez, Tomàs Pumarola Suñé, Sonia Maria Uriona Tuma
Funding agency: EUROPEAN COMMISSION
Funding: 81420
Reference: FLUTCORE_FP7HEALTH2013
Duration: 01/09/2013 - 31/03/2017

Características del paciente y del hospital asociadas a la infección nosocomial por microorganismos resistentes a antibiótios - un análisis multinivel

IP: Jose Angel Rodrigo Pendás
Collaborators: Susana Otero Romero
Funding agency: Instituto de Salud Carlos III
Funding: 21175
Reference: PI15/00787
Duration: 01/01/2016 - 30/11/2020

INCIDENCIA Y HOSPITALIZACIÓN POR HERPES ZÓSTER EN CATALUÑA ENTRE 2007 Y 2017

IP: Magda Campins Martí
Collaborators: Xavier Martínez Gómez, Sonia Maria Uriona Tuma
Funding agency: Instituto de Salud Carlos III
Funding: 24926
Reference: PI15/02273
Duration: 01/01/2016 - 30/11/2020

Cobertura de vacunación antigripal y morbilidad asociada a gripe en gestantes

IP: Magda Campins Martí
Collaborators: Inés Zulema Calero Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 38115
Reference: PI12/02423
Duration: 01/01/2013 - 30/06/2017

Development of a universal inFLUenza vaccine based on Tandem CORE technology (FLUTCORE) Grant Agreement nº 602437

IP: Magda Campins Martí
Collaborators: Jose Angel Rodrigo Pendás, Susana Otero Romero, Xavier Martínez Gómez, Tomàs Pumarola Suñé, Sonia Maria Uriona Tuma
Funding agency: EUROPEAN COMMISSION
Funding: 81420
Reference: FLUTCORE_FP7HEALTH2013
Duration: 01/09/2013 - 31/03/2017

Características del paciente y del hospital asociadas a la infección nosocomial por microorganismos resistentes a antibiótios - un análisis multinivel

IP: Jose Angel Rodrigo Pendás
Collaborators: Susana Otero Romero
Funding agency: Instituto de Salud Carlos III
Funding: 21175
Reference: PI15/00787
Duration: 01/01/2016 - 30/11/2020

INCIDENCIA Y HOSPITALIZACIÓN POR HERPES ZÓSTER EN CATALUÑA ENTRE 2007 Y 2017

IP: Magda Campins Martí
Collaborators: Xavier Martínez Gómez, Sonia Maria Uriona Tuma
Funding agency: Instituto de Salud Carlos III
Funding: 24926
Reference: PI15/02273
Duration: 01/01/2016 - 30/11/2020

Cobertura de vacunación antigripal y morbilidad asociada a gripe en gestantes

IP: Magda Campins Martí
Collaborators: Inés Zulema Calero Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 38115
Reference: PI12/02423
Duration: 01/01/2013 - 30/06/2017

Development of a universal inFLUenza vaccine based on Tandem CORE technology (FLUTCORE) Grant Agreement nº 602437

IP: Magda Campins Martí
Collaborators: Jose Angel Rodrigo Pendás, Susana Otero Romero, Xavier Martínez Gómez, Tomàs Pumarola Suñé, Sonia Maria Uriona Tuma
Funding agency: EUROPEAN COMMISSION
Funding: 81420
Reference: FLUTCORE_FP7HEALTH2013
Duration: 01/09/2013 - 31/03/2017

Cobertura de vacunación antigripal y morbilidad asociada a gripe en gestantes

IP: Magda Campins Martí
Collaborators: Inés Zulema Calero Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 38115
Reference: PI12/02423
Duration: 01/01/2013 - 30/06/2017

Development of a universal inFLUenza vaccine based on Tandem CORE technology (FLUTCORE) Grant Agreement nº 602437

IP: Magda Campins Martí
Collaborators: Jose Angel Rodrigo Pendás, Susana Otero Romero, Xavier Martínez Gómez, Tomàs Pumarola Suñé, Sonia Maria Uriona Tuma
Funding agency: EUROPEAN COMMISSION
Funding: 81420
Reference: FLUTCORE_FP7HEALTH2013
Duration: 01/09/2013 - 31/03/2017

Cobertura de vacunación antigripal y morbilidad asociada a gripe en gestantes

IP: Magda Campins Martí
Collaborators: Inés Zulema Calero Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 38115
Reference: PI12/02423
Duration: 01/01/2013 - 30/06/2017

Development of a universal inFLUenza vaccine based on Tandem CORE technology (FLUTCORE) Grant Agreement nº 602437

IP: Magda Campins Martí
Collaborators: Jose Angel Rodrigo Pendás, Susana Otero Romero, Xavier Martínez Gómez, Tomàs Pumarola Suñé, Sonia Maria Uriona Tuma
Funding agency: EUROPEAN COMMISSION
Funding: 81420
Reference: FLUTCORE_FP7HEALTH2013
Duration: 01/09/2013 - 31/03/2017

Validation of the national/regional Point Prevalence Survey of healtchare-associated infections and antimicrobial use in acute care hospitals in Spain

IP: -
Collaborators: -
Funding agency: European Centre for Disease Prevention and Control
Funding: 10000
Reference: ECDC-3461
Duration: 04/06/2012 - 31/12/2012

Estudio de la efectividad de la vacunación antigripal en la reducción del riesgo de muerte y hospitalizaciones en los ancianos

IP: -
Collaborators: Xavier Martínez Gómez
Funding agency: Instituto de Salud Carlos III
Funding: 63525
Reference: PI070560
Duration: 01/01/2008 - 30/12/2010

Estudio de la efectividad de la vacunación antigripal en la reducción del riesgo de muerte y hospitalizaciones en los ancianos

IP: -
Collaborators: Xavier Martínez Gómez
Funding agency: Instituto de Salud Carlos III
Funding: 63525
Reference: PI070560
Duration: 01/01/2008 - 30/12/2010

Establecimiento de un modelo para mejorar la comparabilidad de los resultados del Estudiio de Prevalencia de las Infecciones Nosocomiales en España (EPINE)

IP: -
Collaborators: Lluis Armadans Gil
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI07/90255
Duration: 01/01/2008 - 31/12/2009

Estudio de la efectividad de la vacunación antigripal en la reducción del riesgo de muerte y hospitalizaciones en los ancianos

IP: -
Collaborators: Xavier Martínez Gómez
Funding agency: Instituto de Salud Carlos III
Funding: 63525
Reference: PI070560
Duration: 01/01/2008 - 30/12/2010

Establecimiento de un modelo para mejorar la comparabilidad de los resultados del Estudiio de Prevalencia de las Infecciones Nosocomiales en España (EPINE)

IP: -
Collaborators: Lluis Armadans Gil
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI07/90255
Duration: 01/01/2008 - 31/12/2009

Strengthening Healhcare Epidemiology and Investigation of Nosocomial Infections in the Mediterranean Area

IP: -
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 33000
Reference: ICA3-2000-30010
Duration: 01/03/2001 - 01/03/2004

Análisis de la evolución de la prevalencia de las infecciones nosocomiales en España.

IP: -
Collaborators: Lluis Armadans Gil, Magda Campins Martí
Funding agency: Instituto de Salud Carlos III
Funding: 7590
Reference: PI020765
Duration: 06/11/2002 - 06/11/2004

Análisis coste-efectividad de los productos sanitarios con mecanismos de seguridad para prevenir las exposiciones percutáneas con alto riesgo de transmisión de microorganismos séricos

IP: Lluis Armadans Gil
Collaborators: José María Sánchez García, Magda Campins Martí
Funding agency: Instituto de Salud Carlos III
Funding: 1983.34
Reference: 01/1391
Duration: 17/07/2001 - 31/08/2003

Strengthening Healhcare Epidemiology and Investigation of Nosocomial Infections in the Mediterranean Area

IP: -
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 33000
Reference: ICA3-2000-30010
Duration: 01/03/2001 - 01/03/2004

Análisis de la evolución de la prevalencia de las infecciones nosocomiales en España.

IP: -
Collaborators: Lluis Armadans Gil, Magda Campins Martí
Funding agency: Instituto de Salud Carlos III
Funding: 7590
Reference: PI020765
Duration: 06/11/2002 - 06/11/2004

Análisis coste-efectividad de los productos sanitarios con mecanismos de seguridad para prevenir las exposiciones percutáneas con alto riesgo de transmisión de microorganismos séricos

IP: Lluis Armadans Gil
Collaborators: José María Sánchez García, Magda Campins Martí
Funding agency: Instituto de Salud Carlos III
Funding: 1983.34
Reference: 01/1391
Duration: 17/07/2001 - 31/08/2003

Strengthening Healhcare Epidemiology and Investigation of Nosocomial Infections in the Mediterranean Area

IP: -
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 33000
Reference: ICA3-2000-30010
Duration: 01/03/2001 - 01/03/2004

Análisis de la evolución de la prevalencia de las infecciones nosocomiales en España.

IP: -
Collaborators: Lluis Armadans Gil, Magda Campins Martí
Funding agency: Instituto de Salud Carlos III
Funding: 7590
Reference: PI020765
Duration: 06/11/2002 - 06/11/2004

Análisis coste-efectividad de los productos sanitarios con mecanismos de seguridad para prevenir las exposiciones percutáneas con alto riesgo de transmisión de microorganismos séricos

IP: Lluis Armadans Gil
Collaborators: José María Sánchez García, Magda Campins Martí
Funding agency: Instituto de Salud Carlos III
Funding: 1983.34
Reference: 01/1391
Duration: 17/07/2001 - 31/08/2003

Strengthening Healhcare Epidemiology and Investigation of Nosocomial Infections in the Mediterranean Area

IP: -
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 33000
Reference: ICA3-2000-30010
Duration: 01/03/2001 - 01/03/2004

Efecto de la vigilancia post-alta sobre la incidencia de las infecciones de la herida quirúrgica.

IP: -
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 11299.03
Reference: 99/1008
Duration: 01/11/1999 - 01/11/2000

Efecto de la vigilancia post-alta sobre la incidencia de las infecciones de la herida quirúrgica.

IP: -
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 11299.03
Reference: 99/1008
Duration: 01/11/1999 - 01/11/2000

Publications

A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain).

PMID: 34842496
Journal: Emerging Microbes & Infections
Year: 2022
Reference: Emerg Microbes Infect. 2022 Dec;11(1):172-181. doi: 10.1080/22221751.2021.2011617.
Impact factor: 7.163
Publication type: Paper in international publication
Authors: Andres, Cristina; Pinana, Maria; Borras-Bermejo, Blanca; Gonzalez-Sanchez, Alejandra; Garcia-Cehic, Damir; Esperalba, Juliana; Rando, Ariadna; Zules-Ona, Ricardo-Gabriel; Campos, Carolina; Codina, Maria Gema et al.
DOI: 10.1080/22221751.2021.2011617

Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing-remitting multiple sclerosis patients.

PMID: 34596743
Journal: JOURNAL OF NEUROLOGY
Year: 2022
Reference: J Neurol. 2022 Jan;269(1):452-459. doi: 10.1007/s00415-021-10823-z. Epub 2021 Oct 1.
Impact factor: 4.849
Publication type: Paper in international publication
Authors: Tur, Carmen; Auger, Cristina; Sastre-Garriga, Jaume; Montalban, Xavier; Cobo, Alvaro; Nos, Carlos; Arrambide, Georgina; Castillo, Joaquim; Rio, Jordi; Gasperini, Claudio et al.
DOI: 10.1007/s00415-021-10823-z

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.

PMID: 35105687
Journal: Neurology-Neuroimmunology & Neuroinflammation
Year: 2022
Reference: Neurol Neuroimmunol Neuroinflamm. 2022 Feb 1;9(2). pii: 9/2/e1143. doi: 10.1212/NXI.0000000000001143. Print 2022 Mar.
Impact factor: 8.485
Publication type: Paper in international publication
Authors: Arrambide, Georgina; Zabalza, Ana; Nos, Carlos; Sastre-Garriga, Jaume; Tintore, Mar; Montalban, Xavier; Comabella, Manuel; Espejo, Carmen; Castillo, Joaquin; Otero-Romero, Susana et al.
DOI: 10.1212/NXI.0000000000001143

Reconciling short-term clinical and Immunological outcomes of SARS-CoV-2 vaccination in Solid Organ Transplant recipients.

PMID: 34554648
Journal: AMERICAN JOURNAL OF TRANSPLANTATION
Year: 2022
Reference: Am J Transplant. 2022 Feb;22(2):673-675. doi: 10.1111/ajt.16855. Epub 2021 Oct 5.
Impact factor: 8.086
Publication type: Letter or abstract
Authors: Toapanta, Nestor; Esperalba, Juliana; Campos-Varela, Isabel; Pont, Teresa; Len, Oscar; Campins, Magda; Moreso, Francesc; Crespo, Elena; Munoz, Marina; Lopez, Manuel et al.
DOI: 10.1111/ajt.16855

Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection.

PMID: 34960209
Journal: Vaccines
Year: 2021
Reference: Vaccines (Basel). 2021 Dec 10;9(12). pii: vaccines9121463. doi: 10.3390/vaccines9121463.
Impact factor: 4.422
Publication type: Paper in international publication
Authors: Pares-Badell, Oleguer, Martinez-Gomez, Xavier, Pinos, Laia, Borras-Bermejo, Blanca, Uriona, Sonia, Otero-Romero, Susana, Rodrigo-Pendas, Jose Angel, Cossio-Gil, Yolima, Agusti, Antonia, Aguilera, Cristina et al.
DOI: 10.3390/vaccines9121463

Nosocomial COVID-19. Prospective study in a referral hospital.

PMID: 34384612
Journal: MEDICINA CLINICA
Year: 2021
Reference: Med Clin (Barc). 2021 Jul 26. pii: S0025-7753(21)00433-4. doi: 10.1016/j.medcli.2021.07.005.
Impact factor: 1.725
Publication type: Letter whit IF
Authors: Escola-Verge, Laura, Borras-Bermejo, Blanca, Los-Arcos, Ibai, Esperalba, Juliana, Ferrer, Carmen, Fernandez-Hidalgo, Nuria et al.
DOI: 10.1016/j.medcli.2021.07.005

Epidemiological characteristics and outcomes of COVID-19 cases: mortality inequalities by socio-economic status, Barcelona, Spain, 24 February to 4 May 2020.

PMID: 34018483
Journal: Eurosurveillance
Year: 2021
Reference: Euro Surveill. 2021 May;26(20). doi: 10.2807/1560-7917.ES.2021.26.20.2001138.
Impact factor: 6.307
Publication type: Paper in international publication
Authors: Martin-Sanchez, Mario, Mercuriali, Lilas, Borras-Bermejo, Blanca, Lopez-Contreras, Joaquin, Vilella, Anna, Villar, Judit, Orcau, Angels, de Olalla, Patricia Garcia, Rius, Cristina, de Andres, Anna et al.
DOI: 10.2807/1560-7917.ES.2021.26.20.2001138

Influence of organization and demographic characteristics of primary care practices on continuity of care: analysis of a retrospective cohort from 287 primary care practices covering about 6 million people in Catalonia.

PMID: 33761874
Journal: BMC Family Practice
Year: 2021
Reference: BMC Fam Pract. 2021 Mar 25;22(1):56. doi: 10.1186/s12875-021-01414-y.
Impact factor: 2.497
Publication type: Paper in international publication
Authors: Coma, Ermengol, Mora, Nuria, Peremiquel-Trillas, Paula, Benitez, Mencia, Mendez, Leonardo, Mercade, Albert, Fina, Francesc, Fabregas, Mireia, Medina, Manuel et al.
DOI: 10.1186/s12875-021-01414-y

Prevalence of asymptomatic SARS-CoV-2 infection in children undergoing hospital screening.

PMID: 33160709
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2020
Reference: Enferm Infecc Microbiol Clin. 2020 Oct 13. pii: S0213-005X(20)30316-5. doi: 10.1016/j.eimc.2020.10.004.
Impact factor: 1.654
Publication type: Letter whit IF
Authors: Soler-Palacin, Pere, Borras-Bermejo, Blanca, Anton, Andres, Soriano-Arandes, Antoni et al.
DOI: 10.1016/j.eimc.2020.10.004

Comparative evaluation of community interventions for the immigrant population of Latin American origin at risk for Chagas disease in the city of Barcelona.

PMID: 32663211
Journal: PLoS One
Year: 2020
Reference: PLoS One. 2020 Jul 14;15(7):e0235466. doi: 10.1371/journal.pone.0235466. eCollection 2020.
Impact factor: 2.74
Publication type: Paper in international publication
Authors: de Los Santos, Juan Jose, Gomez I Prat, Jordi, Peremiquel-Trillas, Paula, Claveria Guiu, Isabel, Caro Mendivelso, Johanna, Choque, Estefa, Albajar Vinas, Pedro, Ascaso Terren, Carlos, Ouaarab Essadek, Hakima, Sulleiro, Elena et al.
DOI: 10.1371/journal.pone.0235466

["Heparjoc-Actua": educational tool created through a process of participatory action research with vulnerable immigrant groups to improve accessibility to diagnosis of hepatitis B.]

PMID: 32632084
Journal: Revista Espanola de Salud Publica
Year: 2020
Reference: Rev Esp Salud Publica. 2020 Jul 7;94.
Impact factor: 0.746
Publication type: Paper in national publication
Authors: Ouaarab Essadek, Hakima, Borras Bermejo, Blanca, Caro Mendivelso, Johanna, Rodriguez Arjona, L Laia, Bisobe, Apolonia, Claveria Guiu, Isabel, Gomez I Prat, Jordi et al.
DOI:

Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020.

PMID: 32574139
Journal: EMERGING INFECTIOUS DISEASES
Year: 2020
Reference: Emerg Infect Dis. 2020 Sep;26(9). doi: 10.3201/eid2609.202603. Epub 2020 Jun 23.
Impact factor: 6.259
Publication type: Paper in international publication
Authors: Abadias, Maria Jose, Roman, Antonio, Pumarola, Tomas, Campins, Magda, Almirante, Benito, Selvi, Marta, Martin, Elisabet, Anton, Andres, Esperalba, Juliana, Borras-Bermejo, Blanca et al.
DOI: 10.3201/eid2609.202603

[Medical errors, the third leading cause of death in the United States?]

PMID: 31735582
Journal: Journal of healthcare quality research
Year: 2019
Reference: J Healthc Qual Res. 2019 Nov - Dec;34(6):339-341. doi: 10.1016/j.jhqr.2019.06.005. Epub 2019 Nov 15.
Impact factor: 0
Publication type: Letter or abstract
Authors: Roel, E, Garcia-Diez, M, Borras Bermejo, B et al.
DOI: 10.1016/j.jhqr.2019.06.005

Evaluation of perceived quality in non-restrictive interventions within the antimicrobial stewardship program in pediatrics (PROA-NEN).

PMID: 30606492
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2019
Reference: Enferm Infecc Microbiol Clin. 2019 Mar;37(3):215-217. doi: 10.1016/j.eimc.2018.11.012. Epub 2018 Dec 31.
Impact factor: 1.685
Publication type: Letter or abstract
Authors: Barcelo, Maria Estrella, Navarro-Royo, Elisa, Melendo-Perez, Susana, Fenoy-Alejandre, Marina, Morey-Olive, Miriam, Soler-Palacin, Pere, Soler-Palacin, Pere, Melendo-Perez, Susana, Mendoza-Palomar, Natalia, Fernandez-Polo, Aurora et al.
DOI: 10.1016/j.eimc.2018.11.012

A Community-Based Intervention for the Detection of Chagas Disease in Barcelona, Spain.

PMID: 31222620
Journal: JOURNAL OF COMMUNITY HEALTH
Year: 2019
Reference: J Community Health. 2019 Aug;44(4):704-711. doi: 10.1007/s10900-019-00684-z.
Impact factor: 1.572
Publication type: Paper in international publication
Authors: Gomez I Prat, Jordi, Peremiquel-Trillas, Paula, Claveria Guiu, Isabel, Choque, Estefa, Oliveira Souto, Ines, Serre Delcor, Nuria, Sulleiro, Elena, Espasa, Mateu, Pastoret, Conxita, de Los Santos, Juan Jose et al.
DOI: 10.1007/s10900-019-00684-z

Infections with Mycobacterium chimaera and open chest surgery. An unresolved problem.

PMID: 30509614
Journal: MEDICINA CLINICA
Year: 2019
Reference: Med Clin (Barc). 2019 Apr 18;152(8):317-323. doi: 10.1016/j.medcli.2018.10.013. Epub 2018 Dec 1.
Impact factor: 1.277
Publication type: Review in national publication
Authors: Campins Marti, Magda, Borras Bermejo, Blanca, Armadans Gil, Lluis et al.
DOI: 10.1016/j.medcli.2018.10.013

Genetic diversity of rhinoviruses detected at a tertiary hospital in Catalonia (Spain) during the 2014-2017 seasons.

PMID: 30417657
Journal: Future Microbiology
Year: 2018
Reference: Future Microbiol. 2018 Nov;13:1565-1573. doi: 10.2217/fmb-2018-0151. Epub 2018 Nov 12.
Impact factor: 3.19
Publication type: Paper in international publication
Authors: Campins-Marti, Magda, Andres, Cristina, Peremiquel-Trillas, Paula, Gimferrer, Laura, Isern, Anna, Pinana, Maria, Rodrigo-Pendas, Jose Angel, Codina, Maria Gema, Martin, Maria Del Carmen, Fuentes, Francisco et al.
DOI: 10.2217/fmb-2018-0151

Thesis

Inmunización materna: Cobertura de vacunación antigripal y morbilidad asociada a la gripe en gestantes en Cataluña. El papel de ginecólogos-obstetras y matronas en la promoción de la inmunización materna

PhD student: Luz Maria Vilca Yengle
Director/s: Magda Campins Martí
University: Universitat Autònoma de Barcelona
Year: 2019

Cobertura vacunal y morbilidad asociada a gripe en embarazadas de Cataluña

PhD student: Luz Maria Vilca Yengle
Director/s: Magda Campins Martí
University: Universitat Autònoma de Barcelona
Year: 2018

Eventos adversos en medicina intensiva neonatal: hacia una atención de calidad y segura

PhD student: Yuani Miriam Román Morillo
Director/s: Magda Campins Martí
University: Universitat Autònoma de Barcelona
Year: 2017

Estudio de incidencia de infección de herida quirúrgica en las prótesis totales de cadera y rodilla (1998-2012)

PhD student: José María Sánchez García
Director/s: Josep Vaqué Rafart
University: Universitat Autònoma de Barcelona
Year: 2016

Epidemiología de la Esclerosis Múltiple en Catalunya

PhD student: Susana Otero Romero
Director/s: Xavier Montalban Gairín, Jaume Sastre Garriga, Josep Vaqué Rafart
University: Universitat Autònoma de Barcelona
Year: 2016

Comparación de la incidencia de tos ferina declarada con la incidencia de hospitalización por tos ferina en España

PhD student: Maria Isabel Fernández Cano
Director/s: Magda Campins Martí, Lluis Armadans Gil
University: Universitat Autònoma de Barcelona
Year: 2016

Vacunación antigripal y antineumocócica en niños con patología de base de riesgo

PhD student: Roser González Baulies
Director/s: Magda Campins Martí
University: Universitat Autònoma de Barcelona
Year: 2015

Noves aportacions a la vigilància, prevenció i control del vih i d'altres infeccions de transmissió sexual a Catalunya

PhD student: Dolors Carnicer Pont
Director/s: Josep Vaqué Rafart
University: Universitat Autònoma de Barcelona
Year: 2015

Patrones endémicos de la hanseniasis en Pernambuco, Brasil

PhD student: Flavia Maria Barkokebas
Director/s: Josep Vaqué Rafart
University: Universitat Autònoma de Barcelona
Year: 2014

12. La dirección de operaciones en un hospital de alta tecnología. Medidas para incrementar la productividada y la eficiencia

PhD student: Berta Ortiga Fontgivell
Director/s:
University: Universitat Autònoma de Barcelona
Year: 2013

Análisis de las necesidades de recursos sanitarios en los pacientes con ictus en Barcelona ciudad

PhD student: Elvira Torné Vilagrasa
Director/s: Josep Vaqué Rafart
University: Universitat Autònoma de Barcelona
Year: 2013

Estudio de incidencia de la listeriosis en España

PhD student: Fernando Parrilla Valero
Director/s: Josep Vaqué Rafart
University: Universitat Autònoma de Barcelona
Year: 2012

Signos de peligro en el paciente con malaria. Valor pronóstico de signos clínicos y parasitológicos

PhD student: Alberto Tobón Castaño
Director/s: Josep Vaqué Rafart
University: Universitat Autònoma de Barcelona
Year: 2011

Blog

News

A l'estudi hi participaran 200 persones voluntàries i es durà a terme a 10 hospitals espanyols, entre els quals Vall d’Hebron.

Entre els projectes més rellevants en Covid-19 destaca la participació del VHIR en assaigs clínics per provar l’eficàcia i seguretat de vacunes com ara Janssen, Pfizer-BioNTech en el col·lectiu d’embarassades, i Hipra.

The trial, which already has AEMPS authorisation, will be conducted in Spain, Portugal and Italy.

Job offers

Clinical Support Epidemiology and Public Health research group.
Start date:
25/01/2022
End date:
01/02/2022
Document: Download
Administrative support - Epidemiology and Public Health research group
Start date:
01/12/2021
End date:
15/12/2021
Document: Download
Laboratory Technician
Start date:
12/07/2021
End date:
26/07/2021
Document: Download